Ascentage Pharma Group International(HK:6855)
HK$25.62-0.50 (-1.91%)
HK:6855
Ascentage Pharma Group International financials statements
HK$25.62
At close:-0.50 (-1.91%)
Want to see HK:6855 full AI Analyst Report?
Ascentage Pharma Group International (6855) Income Statement
5 Followers
Ascentage Pharma Group International Income Statement
Last quarter (Q2 2026), Ascentage Pharma Group International's total revenue was ¥298.04M, a decrease of 63.82% from the same quarter last year. In Q2, Ascentage Pharma Group International's net income was ¥-805.42M. See Ascentage Pharma Group International’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 559.26M | ¥ 980.65M | ¥ 221.98M | ¥ 209.71M | ¥ 27.91M | |
| ¥ 427.35M | ¥ 951.57M | ¥ 191.44M | ¥ 187.71M | ¥ 24.58M | |
| ¥ 1.61B | ¥ 1.33B | ¥ 1.08B | ¥ 1.07B | ¥ 957.75M | |
| Depreciation and Amortization | ¥ 86.48M | ¥ 93.17M | ¥ 93.19M | ¥ 62.91M | ¥ 28.33M |
| ¥ -1.09B | ¥ -285.63M | ¥ -743.61M | ¥ -820.49M | ¥ -904.84M | |
| ¥ -1.18B | ¥ -378.80M | ¥ -891.99M | ¥ -883.41M | ¥ -933.17M | |
| ¥ -23.24M | ¥ -16.45M | ¥ -40.87M | ¥ -3.77M | ¥ 100.92M | |
| ¥ -1.20B | ¥ -395.25M | ¥ -932.86M | ¥ -887.17M | ¥ -832.25M | |
| ¥ -1.21B | ¥ -405.43M | ¥ -925.64M | ¥ -882.92M | ¥ -782.42M | |
| Per Share Metrics | |||||
| Basic EPS | ¥ -3.40 | ¥ -1.34 | ¥ -3.28 | ¥ -3.35 | ¥ -3.07 |
| Diluted EPS | ¥ -3.40 | ¥ -1.34 | ¥ -3.28 | ¥ -3.35 | ¥ -3.07 |
| Weighted Average Shares Outstanding | 356.13M | 302.06M | 282.30M | 263.67M | 254.62M |
| Weighted Average Shares Outstanding (Diluted) | 356.13M | 302.06M | 282.30M | 263.67M | 254.62M |
Currency in CNY

